Abstract Genetic engineering of peanut (Arachis hypogaea L
Introduction
Peanut (Arachis hypogaea L.) is a popular legume crop, cultivated in over 100 countries across the six continents as a rich source of edible oil (43-55 %), protein (23-28 %) and carbohydrates (10-15 %) . With an annual world production of 37.2 million tons from 23.4 million ha, peanut is a major oilseed crop that is grown commercially throughout the tropical, subtropical and warm temperate regions of the world [20] . It is largely a small-holder crop, grown under rainfed conditions in semi-arid areas characterized by unpredictable rainfall, and these areas contribute over 90 % of world peanut production. The low yields of peanut are primarily due to low inputs, rainfed cultivation of the crop in marginal lands, non-availability of seed of suitable high-yielding varieties, and the occurrence of many insect pests, fungal diseases, and numerous viral diseases at different stages of crop growth.
Peanut bud necrosis virus (PBNV) is a member of the genus Tospovirus, which includes arthropod-borne, plantinfecting members of the family Bunyaviridae [26] , and it is transmitted by thrips (Thrips palmi Karmy) in a persistent manner [38] . PBNV is economically important in South and Southeast Asian countries, including India, Nepal, Sri Lanka, Myanmar, Thailand and parts of China [25] . The disease incidence has been reported to be up to 50 % in major peanut-growing areas and causes yield losses of over 80 % in the early infected crop [24] . Control of this virus through cultural practices such as crop rotation, chemical control of thrips vectors, and removal of alternate weed hosts have met with limited success. Hence, the development of virus-resistant host plant varieties is the most promising means of controlling virus diseases in the long term. At the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT), although over 8,000 germplasm accessions have been evaluated to identify resistance to PBNV, durable resistance has not been found, with the exception of a few lines that were moderately resistant to the vector [7] . While members of a few wild species of the genus Arachis have shown good levels of resistance to PBNV, they are sexually incompatible with the cultivated varieties and have low yields [1] . Thus, it has become imperative to look for alternative approaches, and one of the best possible options is the development of PBNV-resistant transgenic peanut plants. Genetically engineered resistance has been actively investigated in recent years as an attractive option [15] . Expression of virus-derived genes in transgenic host plants has been shown to result in reduced susceptibility of the plant to virus infection, and the degree of protection has ranged from a delay in symptom expression to absence of symptoms and virus accumulation [10] . The gene encoding the nucleocapsid protein (N gene) of viruses has been used extensively to impart disease resistance in various crop plants, and the resistance acquired was correlated either to an RNA-mediated mechanism or high N protein accumulation [8, 13, 22, 34] . Transgenic peanut plants have previously been developed for resistance to various viral diseases by using the viral coat protein and/or replicase genes [5, 6, 11, 15, 30] . Although the use of the N gene of PBNV has been demonstrated in Nicotiana tabacum [37] , there are no reports on the development and evaluation of transgenic peanut plants for conferring resistance to PBND. Considering the importance and scope of PBND, the present research work was undertaken to develop and evaluate transgenic peanut plants using the viral N gene for pathogen-derived resistance against PBNV.
Materials and methods

Plasmid constructs
The N gene of PBNV (ICRISAT isolate), consisting of 831 nucleotides and encoding a protein of 276 amino acids with a predicted molar mass of 30.6 kDa, was sequenced and cloned in pGEM5Z [28] . The plasmid pGEM5Z, carrying 831 bp of the N gene coding sequence was subcloned into the NcoI and SacI sites of the plasmid pRTL2. The resulting plasmid, pRTL2:PBNV N-gene (4,731 bp; Online Resource 1), which was maintained in E. coli strain DH5a, has a double CaMV 35S promoter with a tobacco etch virus (TEV) leader sequence for enhanced expression of the N gene and was used for transformation by the biolistic method.
For Agrobacterium tumefaciens-mediated genetic transformation, the plasmid pRTL2:PBNV N-gene was digested with SphI, and the end-filled ''N'' fragment, along with the promoter (1,853 bp), was subcloned into the endfilled BamHI site of the binary vector pCAMBIA1301 carrying the reporter gene uidA (GUS) with an intron driven by the CaMV 35S promoter and nos poly-A terminator sequences along with a CaMV 35S-promoter-driven hygromycin phosphotransferase (hpt) as the selectable marker gene. The new plasmid was designated as pCAM-BIA1301:PBNV N-gene (Online Resource 1) and mobilized into A. tumefaciens strain C 58.
Plant material and transformation
Mature seeds of a popular Spanish-type peanut cultivar, JL 24, were used in all experiments. For biolistic-mediated gene transfer (BM), a protocol developed earlier [16] was followed, using the cotyledons and embryonic leaves as explants, which were bombarded with the plasmid pRTL2:PBNV N-gene. The PDS-1000 He system (BioRadÒ) was used for biolistics using gold particle microcarriers (1 lm diameter) at a helium gas pressure of 12 kg/ cm 2 and partial vacuum of 600 mmHg. A peanut transformation protocol reported previously [30] was followed for the development of transgenic plants via A. tumefaciens-mediated gene transfer (AM). For this, the cotyledon explants from mature pre-soaked seeds were co-cultivated with A. tumefaciens strain C 58 harboring the binary plasmid pCAMBIA 1301:PBNV N-gene.
DNA isolation and PCR analysis
Molecular studies were carried out to confirm the integration and expression of the introduced genes in the putative transgenic plants. The genomic DNA was isolated from the control (untransformed peanut) and putative transgenic plants using a previously published method [30, 31] . The presence of the hpt and PBNV N genes in the putative transformants was confirmed by polymerase chain reaction (PCR). A 819-bp region of hpt was amplified using 22-mer oligonucleotide primers (hpt forward primer, 5 0 -CGT TAT GTT TAT CGG CAC TTT G-3 0 ; hpt reverse primer, 5 0 -GGG GCG TCG GTT TCC ACT ATC G-3 0 ). A 585-bp coding region of the N gene was amplified by using 22-mer oligonucleotide primers (N forward primer, 5 0 -GCT TGT AAA AGT GGT AAG TAT G-3 0 ; N reverse primer, 5 0 -ATA ATC ATC CAT TGA GAG ACT G-3 0 ). For PCR amplification, the genomic DNA was denatured at 94°C for 5 min, followed by denaturation at 94°C for 30 s, annealing at 55°C for 45 s and extension at 72°C for 1 min for 30 cycles, and then a final elongation step at 72°C for 10 min.
Analysis of gene expression by RT-PCR
For RT-PCR analysis, total RNA was isolated from 100 mg plant tissue by using TRIzol Reagent (Invitrogen, USA). Before synthesizing cDNA, the total RNA was treated with one unit of DNase I and incubated at 37°C to eliminate the residual DNA. All of the reagents and conditions used were as described for the Protoscript RT-PCR system for synthesizing the cDNA (New England Biolabs, USA).
Southern blot analysis
The putative T 0 transformants were subjected to Southern blot hybridization by digesting 15 lg of the genomic DNA with SphI to release the PBNV N gene, including the promoter and poly A sequences of pRTL2:PBNV N-gene, and with XbaI to release the PBNV N gene, including the promoter of pCAMBIA:PBNV N-gene. To determine the copy number of the inserts, genomic DNA from the selected events in the T 1 and T 2 generations was digested with restriction enzymes that cut only once within the T-DNA region: XbaI for pRTL2:PBNV N-gene and SphI for pCAMBIA:PBNV N-gene. The digested DNA was separated by electrophoresis on a 0.8 % agarose gel and transferred to a nylon membrane (Hybond N?, Amersham) [27] . A PCR-amplified 585-bp fragment of the PBNV N gene was used as a probe after labeling it using the nonradioactive AlkPhos direct system (Amersham). Labeling, hybridization and detection were performed according to the manufacturer's instructions.
DAC-ELISA and western blotting DAC-ELISA was carried out to detect the presence of PBNV in transgenic plants that were challenged with the virus in greenhouse experiments, and for the confirmation of natural infection of plants in field experiment studies. The antiserum that was used for western blotting was also used for DAC-ELISA. ELISA tests were carried out once for the infected leaves (after 1 week) and twice for the systemic leaves at 20 and 30 days after inoculation. The standard protocol for direct antigen-coated ELISA was followed [23] . Leaf extracts (100 mg in 1 ml of 50 mM sodium carbonate buffer, pH 9.6) were coated onto the wells of an ELISA plate (MaxiSorb, NUNC). PBNV antibodies at a dilution of 1:10,000 (v/v) were added into the wells of the ELISA plate and incubated at 37°C for 1 h, followed by incubation with alkaline-phosphatase-conjugated goat anti-rabbit IgG antibody for 1 h at 37°C. p-nitrophenyl phosphate (0.05 mg/mL) was used as a substrate before incubating the plates at room temperature. The reaction was measured in an ELISA plate reader fitted with a 405-nm filter (SpectraMax Plus microplate reader, Molecular Devices, USA) after addition of the substrate and incubation of the plates for 30, 60 or 120 min.
Western blotting was carried out to analyze the expression level of the N protein, using the protein isolated with TRIzol Reagent (Invitrogen, USA) and PBNV NP antibodies. The total protein was isolated from 500 mg leaf tissue under liquid nitrogen, extracted in 0.5 ml of 0.03 M potassium phosphate buffer (pH 7.5) and 10 mM 2-mercaptoethanol, and centrifuged at 13,000 rpm for 5 min. The protein content in the extract was quantified by the Bradford method (Bradford 1976). Fifty lg of the protein was combined with equal volumes of Laemmli buffer, heat-denatured by boiling in a water bath for 3 min, and separated by 12 % sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) followed by immunoblotting onto a nitrocellulose membrane using a semi-dry transfer apparatus [27] . The PBNV NP was detected using a rabbit anti-PBNV NP polyclonal serum as a primary antibody (cross-absorbed polyclonal antibody) and goat anti-rabbit IgG coupled to alkaline phosphatase (Sigma catalog no. A3687) as a secondary antibody. Positive reactions were detected using BCIP-NBT substrate (Sigma catalog no. B1911).
Virus challenge studies PBNV (ICRISAT isolate) maintained on cowpea plants was used for preparation of the inoculum. Thirty-five T 1 transgenic events (20 events produced using BM and 15 produced using AM) were selected for bioassays under P2-level greenhouse conditions. Nine seeds from each transgenic event, including a susceptible control, JL 24, were sown and replicated three times. All of the test plants were examined for integration of the transgene by PCR and RT-PCR. From each event, six seedlings were selected for inoculation, and the remaining three were kept as uninoculated controls. Virus inoculum was freshly prepared from the infected leaves of cowpea ground in 50 lM potassium phosphate buffer at 1:100 dilution (w/v) under ice-cold conditions. The virus inoculum was rubbed onto all of the opened leaves of 8-to 10-day-old test seedlings and rinsed with deionised water after 2 h. All of the pots were maintained at 25°C and 75 % RH in a contained greenhouse for uniform infection. Disease development on the inoculated plants was monitored by DAC-ELISA tests and visual observations. The observations that were recorded included the number and percent of plants infected in each transgenic event, the number of positive plants showing infection, the number of negative plants showing infection, and percentage increase/decrease of disease over the control plants. The plants that did not show infection were advanced to further generations for subsequent evaluations.
In another set of experiments, 24 T 2 -generation transgenic lines involving 13 events from AM and 11 events from BM, including four lines derived from cotyledonory explants and seven derived from embryonic leaf transformation, were used for virus challenge studies with the sap extracts (1:50 w/v).
Contained field evaluation
A contained field trial was conducted following approval from the regulatory authorities in India. The field trial was carried out in an isolated area on the farms of ICRISAT, Patancheru, India, during August-December in 2005. Twenty-four T 2 transgenic lines that had previously been screened in greenhouse virus-challenge tests were selected and evaluated. The field trial was done using plants from 24 test events and four controls of the non-transgenic peanut variety JL 24 in three replications. Each test event and control had eight seeds per replication and was planted in two rows at a distance of 30 9 50 cm in a plot size of 1 9 1.2 m. Each plot was separated by an 80-cm space, and each replication was separated from the others by 1.0-m alley paths. Two rows of non-transgenic peanut and pearl millet were grown surrounding the experimental areas as trap crops. Observations on the number of diseasefree and diseased plants were recorded periodically. Among the infected plants, the severity of the disease, viz., mosaic leaf symptoms (MLS), apical bud necrosis (ABN), severe necrosis (SN), and mortality (M) were recorded separately for each event and compared with controls. All of the plants, irrespective of symptoms, were tested by ELISA for the presence or absence of PBNV. The observations on disease incidence (DI) were recorded, and analysis of data for the actual number of positive plants in each event was carried out.
Statistical analysis
Transformation experiments were conducted using a randomized design and repeated at least three times. Data from greenhouse and field studies were analyzed by analysis of variance (ANOVA) to detect significant differences between the means.
Results
Genetic transformation studies
A total of 900 cotyledon and embryonic leaflet explants of peanut were used in three batches through Agrobacteriumand biolistic-mediated genetic transformation with the PBNV N gene resulting in a total of 375 putative transformants (Online Resource 2). The shoot buds induced in Agrobacterium-mediated gene transfer were initially selected with 2 lg ml -1 hygromycin (2 lg ml -1 ) followed by selection on 5 lg ml -1 hygromycin during the subsequent subcultures of 2-3 weeks until rooting on the selection-free medium.
For the biolistic-mediated gene transfer, the embryonic leaflet explants cultured on the shoot-induction medium (SIM) turned green and underwent considerable enlargement within 2-3 days of culture, followed by the induction of multiple adventitious shoot buds from the petiolar cut ends in over 80 % the explants within 2-3 weeks. After two subcultures on SIM, explants with the differentiated shoot buds were transferred to shoot elongation medium (SEM) for three subcultures of 4 weeks each. The elongated shoots were rescued at the end of each subculture and transferred to root-induction medium (RIM), where they developed adventitious roots in over 77 % of the elongated shoots within 2 weeks. Since there was no antibiotic marker for selection of the transformed plants, PCR was used to select the transformed plants at the rooting and/or greenhouse stage (T 0 generation). The confirmed PCRpositive transgenic events were advanced to further generations.
Molecular analysis
Putative transformants were screened by PCR and RT-PCR analysis to confirm the presence and expression of transgenes (Online Resource 3). Oligonucleotide primers specific for the N (585 bp) and hpt (819 bp) genes were amplified to produce a gene fragment of the expected size in 72 and 83 %, respectively, of the T 0 putative transformants transformed with Agrobacterium tumefaciens. In the other set of transformants that were produced using BM, the transgene amplification indicated a transformation frequency of 39.4 and 44 % in cotyledonary and embryonic leaf explants, respectively. Furthermore, the cDNA isolated from the putative transgenic plants showed amplification of the 585-bp fragment of the N gene in 62 % of AM transformants. However, a relatively lower number (26 %) of the transgenic plants derived from BM expressed the transgene, as shown by RT-PCR.
Southern blot analysis was carried out with the selected transformants in the T 0 and T 1 generations to ascertain the integration and copy number of the transgenes (Fig. 1a, b) . A total of 15 of the 24 tested transgenic plants produced using Agrobacterium-mediated transformation showed hybridization signals, while seven of the 21 plants tested, and 12 of 26 plants tested that were obtained from the BM leaflets and cotyledonary explants, respectively, were positive for the transgene. Moreover, 13 out of the 15 Agrobacterium-mediated transformed plants showed the presence of a single site of integration. Analysis of the putative transgenic plants obtained through BM of embryonic leaflets and cotyledonary explants with the plasmid pRTL2:PBNV N gene revealed single-copy integration in five and four plants, respectively. DAC-ELISA was used with polyclonal antiserum against PBNV (ICRISAT isolate) to detect virus infection in the transgenic plants in the T 1 generation. All of the 35 tested transgenic events showed varied levels of reaction. The OD readings ranged from 0.125 to 1.472, compared to a reading of 2.418 for a PBNV-infected peanut plant that was used as a positive control. PBNV N gene expression in the leaf samples was detected in the transformed plants, but not in the untransformed controls, when tested by immunoblot analysis. The PBNV antibodies detected 33-kDa products that had the same electrophoretic mobility as the PBNV nucleoprotein obtained from infected leaves of wild-type plants (Fig. 1c) .
Segregation analysis PCR analysis of the transgenes was carried out to characterize the inheritance of the transgene in the T 1 and T 2 generations to study the stability of the introduced transgene (Online Resource 4). The results indicated that[95 % of the plants in the T 1 and T 2 generations showed a Mendelian segregation ratio of 3:1.
Greenhouse evaluation
Virus challenge of the transgenic plants using sap extracts prepared from PBNV-infected cowpea plants at a 1:100 dilution was carried out in a contained greenhouse for 35 independent transgenic events in the T 1 generation (20 events with BM) and 15 events derived from AM along with untransformed parent JL 24 ( Table 1 ). The results indicated that 16 out of 35 lines (45.7 %) did not acquire the virus, whereas 19 (54.3 %) that acquired the virus showed varied levels of disease intensity. Among the 19 transgenic plant lines that were infected, the disease incidence (DI) in seven ranged from 1 to 25 %, in five, it was 26-50 %, in six, it was 51-75 %, and in one, it was higher than 75 %. Similarly, variations in infectivity were observed amongst the transgenic events, where six lines (30 %) remained infection-free and 14 produced using BM (70 %) acquired the virus, while ten (66.6 %) produced using AM were free, and five (33.3 %) acquired the virus. The disease incidence (DI) was recorded for each event, and the percent increase or decrease and plant mortality over control was calculated.
Based on preliminary screening, 24 transgenic events (13 produced using AM and 11 produced using BM) were selected for the advancement of generation (T 2 ) so as to repeat the virus challenge at higher virus concentration [1:50] in the greenhouse (Fig. 2) . At this concentration, most of the plants were infected to some extent and showed varying degrees of disease progress and survival (Online Resource 5). Although 100 % of the untransformed control plants died by 3 weeks after inoculation, the transgenic plants did not show any signs of infection until after 2 weeks. The mortality in the transgenic lines due to PBNV infection was recorded as 58.1, 74.8, 84.8, 97 and 100 % in the third, fifth, seventh, ninth, tenth week as well as after ten weeks post-inoculation, respectively, indicating that although two of the transgenic plant lines survived up to 10 weeks post-inoculation, these eventually succumbed to the disease. Twenty-four transgenic lines in the T 2 generation (13 AM and 11 BM) that showed integration of the PBNV N gene and remained either infection-free or had less viral infection following virus challenge tests I and II were selected for evaluation under natural field conditions (Fig. 3) . The initial mosaic symptoms were observed in seedlings from 2 to 3 weeks after germination, and the disease incidence (DI) was monitored and recorded fortnightly until the plants reached maturity. The disease incidence (DI) in the untransformed control plants was 85.4 %, with severity of 16.6, 35.4, 24 and 9.4 % of MLS, ABN, SN and mortality, respectively. Among the test events, the disease incidence and intensity were variable, where the disease incidence (DI) of the test events was measured on a 0-4 scale, viz., 0 (Nil), 1 (1-25 %), 2 (26-50 %), 3 (51-85 %) and 4 ([85 %, maximum disease incidence as untransformed control).
The disease incidence (DI) analyzed on the basis of transformation method indicated that in the transgenic events obtained through BM, one had a lower disease incidence (1-25 %), two had a 26-50 % disease incidence, seven were in a range of 51-85 % disease incidence and one was above 85 %. However, none of the events from AM were in the range of 1-25 % disease incidence, while three had 26-50 % disease incidence, six had 51-85 % disease incidence, and four had a disease incidence of [85 %. Based on these results, nine (from both BM an AM) with a lower disease incidence (35-80 %) over the untransformed controls were identified as better performers under field evaluation (Table 2 ; Fig. 3 ). Overall, in the field evaluation studies, only one transgenic plant line showed a modest reduction in disease incidence (17.7 %) when compared to the other five that showed 42-51 % reduction in disease incidence and to untransformed controls. Also, based on the percent disease resistance (DR), calculated in terms of disease incidence and healthy plants over the control, the progeny of event GNPBNV-B-1 was ranked as best (67 %), followed by GNPBNV-A-K (43.7 %) and GNPBNV B-11 (41.7 %) (Fig. 4) .
Discussion
Introduction of the viral N gene by genetic transformation is a rapid and effective means to generate novel resistance against viral diseases in crop plants. In the present study, transgenic peanut plants were developed for resistance against PBND by introducing the PBNV N gene using two methods of gene transfer. The resulting transgenic plants were analyzed molecularly as well as in virus bioassays under greenhouse and field conditions. A total of 15 transgenic plants were generated using Agrobacterium-mediated transformation [30, 31] , resulting in 43 % regeneration frequency and a transformation frequency of over 72 %. The transformation procedure based on biolistics used for direct gene transfer resulted in overall shoot regeneration and transformation frequencies of 47 and 39.4 %, respectively, with cotyledonary explants, and 34 and 44 %, Disease incidence was measured for 2-7 weeks post-inoculation respectively, with embryonic leaflets. Also, the transformation efficiency obtained in this study by the biolistic method is the highest reported so far when compared to previous reports [2-4, 21, 29, 36] , thereby indicating that embryonic leaflets and half cotyledons of peanut can also be used as suitable explants for transformation of peanut by the biolistic method.
Using both direct and indirect methods for peanut transformation, out of the 35 putative transgenic events tested in the T 0 generation, 22 had single-copy inserts. The number of transgenic events carrying the single copy inserts was lower in the ones produced by the biolistic method when compared to Agrobacterium-mediated transformation. High copy number has been known to be a common feature associated with the biolistic method of transformation [12] . Nevertheless, upon advancement of generations, all the 16 transgenic plants (100 %) in the T 1 generation and 23 out of 24 (96 %) in T 2 generation followed the Mendelian segregation ratio of 3:1. Based on these results, it is evident that the transgene was transmitted to and expressed in the successive progeny.
The virus challenge experiments with T 1 generation transgenic plants of peanut revealed that 16 of the 35 tested transgenic plant lines (45.7 %) did not acquire the virus under the conditions of the greenhouse assays. However, in the T 2 generation, only three transgenic events, viz., GNPBNV B1-2, GNPBNV AK-3 and GNPBNV B11-2, showed a 40 to 67 % decrease in disease incidence and were considered to be superior under greenhouse conditions. These results indicated that 19 out of 35 lines could be infected at a virus dilution of 1:100, whereas at a 1:50 dilution, all of the transgenic plants tested were infected. However, the disease severity varied among the transgenic events at different periods post-inoculation. Most of the plants survived up to 3-9 weeks post-inoculation (WPI), but only two survived up to ten WPI when compared to the untransformed controls, which survived only for two WPI. Based on these preliminary data, the delay in expression of symptoms and mortality was attributed to the resistance gained due to the presence of the transgene in these plants.
Nevertheless, for subsequent contained field evaluations, a high level of natural infection of PBNV prevailed during the test period, which was an added advantage for screening for resistance. Under field conditions, while three transgenic lines (GNPBNV-B-1-2-1, GNPBNV-A-K-3-4 and GNPBNV B-11-2-3) showed a considerable reduction in disease incidence, only one (GNPBNV-B-1-2-1) showed less than 20 % disease incidence and emerged as somewhat resistant to PBND. These variations among the transgenic events under field conditions were comparable to the results of virus challenge test at 1:50 dilution carried out under greenhouse conditions, thereby indicating that the highly efficient mechanical inoculation is likely to introduce a greater amount of virus inoculum when compared to thrips-mediated natural infection [39] . Nevertheless, the transgenic plants in our study had fewer necrotic spots than did controls grown under identical conditions. During the course of the investigation presented here, although most of the transgenic plants were confirmed to express the transgene, only three lines (GNPBNV-B-1-2-1, GNPBNV-A-K-3-4 and GNPBNV B-11-2-3) in the T 2 generation eventually exhibited a considerable level of resistance, while others showed susceptibility or low levels of resistance under greenhouse and field conditions. This indicates the possible occurrence of transgene silencing in these transgenic plants. Occurrence of transgene silencing has also been reported previously in transgenic sorghum plants obtained by the biolistic method of transformation [9] . These results are also in agreement with previous findings in which low to medium expression levels of the viral transgenes in peanut have been observed [15, 18, 39] . Also, progeny of the transgenic peanut plants developed for resistance to alfalfa mosic virus (AMV) accumulated detectable amounts of the viral coat protein but remained susceptible to the virus under greenhouse conditions [35] . This unexpected behavior and considerable variation in the expression of transgenes could not be attributed only to the copy number but were also influenced by other factors such as the strength of the promoter, epigenetic factors, positional effect, inherent host genome, pre-and post-transcriptional, and translational processes [19, 32] . This is the first report on generating transgenic peanut plants exhibiting a modest tolerance to PBND both under greenhouse and field conditions, where one transgenic event showed partial resistance (\20 % disease incidence, DI) under natural infection under field conditions. This apparent lack of resistance to PBND in the transgenic plants could be due to the presence of RNA silencing suppressor gene, (NSs) in the PBNV genome that render the PBNV N gene ineffective [14, 17, 33] . However, considering the unexpectedly low frequency of virusresistant plants throughout the challenge experiments, it is concluded that an alternate strategy based on RNA-interference-mediated gene silencing (antisense and hairpin RNA) could be a potential tool for achieving more efficient protection against PBNV. Fig. 4 Percentage of relative disease resistance in T 2 generation transgenic plants. The selected transgenic plant lines showed improved resistance to PBND during contained field-testing when compared to the untransformed controls. The untransformed controls were considered susceptible to PBND
